As of 2025-05-15, the EV/EBITDA ratio of Spectrum Pharmaceuticals Inc (SPPI) is -2.80. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SPPI's latest enterprise value is 187.87 mil USD. SPPI's TTM EBITDA according to its financial statements is -67.03 mil USD. Dividing these 2 quantities gives us the above SPPI EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.9x - 13.3x | 13.1x |
| Forward P/E multiples | 16.5x - 30.7x | 19.0x |
| Fair Price | (5.27) - (4.22) | (5.13) |
| Upside | -611.4% - -509.3% | -597.8% |
| Date | EV/EBITDA |